Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
3
×
Tags
boston blog main
boston top stories
bristol-myers squibb
3
×
life sciences
3
×
national blog main
national top stories
new york blog main
new york top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
biotech
boulder/denver blog main
boulder/denver top stories
celgene
clinical trials
detroit blog main
detroit top stories
genentech
indiana blog main
indiana top stories
intercept pharmaceuticals
nash
national
nonalcoholic steatohepatitis
obeticholic acid
pfizer
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
starboard value
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
4d molecular therapeutics
abbvie
acc
What
approved
3
×
drug
3
×
bio
disease
fatty
known
liver
nash
news
roundup
adu
beats
bids
biogen
companies
complicated
data
depression
digital
dire
epidemic
fda
frenzied
good
group
growing
heart
help
horizon
intercept
led
marketed
medical
medicine
merck
need
new
nonalcoholic
people
postpartum
Language
Current search:
drug
×
approved
×
" life sciences "
×
photo
×
" bristol-myers squibb "
×
@xconomy.com
5 years ago
Bio Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
With New Data, Intercept On Track for First-Ever Approved NASH Drug